Coordinatore | Medizinische Universitaet Graz
Organization address
address: AUENBRUGGERPLATZ 2 contact info |
Nazionalità Coordinatore | Austria [AT] |
Totale costo | 7˙164˙489 € |
EC contributo | 4˙999˙305 € |
Programma | FP7-INFRASTRUCTURES
Specific Programme "Capacities": Research infrastructures |
Code Call | FP7-INFRASTRUCTURES-2007-1 |
Funding Scheme | CP-CSA-Infra |
Anno di inizio | 2008 |
Periodo (anno-mese-giorno) | 2008-02-01 - 2011-01-31 |
# | ||||
---|---|---|---|---|
1 |
Medizinische Universitaet Graz
Organization address
address: AUENBRUGGERPLATZ 2 contact info |
AT (GRAZ) | coordinator | 0.00 |
2 |
Nome Ente NON disponibile
Organization address
address: Minoritenplatz 5 contact info |
AT (VIENNA) | participant | 0.00 |
3 |
"BIOMEDICAL RESEARCH FOUNDATION, ACADEMY OF ATHENS"
Organization address
address: Soranou Efesiou 4 contact info |
EL (ATHENS) | participant | 0.00 |
4 |
"MINISTERIE VAN ONDERWIJS, CULTUUR EN WETENSCHAP"
Organization address
address: Rijnstraat 50 contact info |
NL (DEN HAAG) | participant | 0.00 |
5 |
ACADEMISCH ZIEKENHUIS GRONINGEN
Organization address
address: Hanzeplein 1 contact info |
NL (GRONINGEN) | participant | 0.00 |
6 |
ACADEMISCH ZIEKENHUIS LEIDEN
Organization address
address: Albinusdreef 2 contact info |
NL (LEIDEN) | participant | 0.00 |
7 |
ALLEANZA CONTRO IL CANCRO
Organization address
address: VIALE DELLA CIVILTA ROMANA 7 contact info |
IT (ROMA) | participant | 0.00 |
8 |
BABRAHAM BIOSCIENCE TECHNOLOGIES LIMITED
Organization address
address: Babraham Hall contact info |
UK (CAMBRIDGE) | participant | 0.00 |
9 |
BUNDESMINISTERIUM FUER BILDUNG UND FORSCHUNG
Organization address
address: Heinemannstrasse 2 contact info |
DE (BONN) | participant | 0.00 |
10 |
CARDIFF UNIVERSITY
Organization address
address: Newport Road 30-36 contact info |
UK (CARDIFF) | participant | 0.00 |
11 |
CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER
Organization address
address: Cours Albert-Thomas 150 contact info |
FR (LYON CEDEX 08) | participant | 0.00 |
12 |
CONSIGLIO NAZIONALE DELLE RICERCHE
Organization address
address: Piazzale Aldo Moro 7 contact info |
IT (ROMA) | participant | 0.00 |
13 |
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM
Organization address
address: 's Gravendijkwal 230 contact info |
NL (ROTTERDAM) | participant | 0.00 |
14 |
EUROPEAN MOLECULAR BIOLOGY LABORATORY
Organization address
address: Meyerhofstrasse 1 contact info |
DE (HEIDELBERG) | participant | 0.00 |
15 |
FEDERATION HOSPITALIERE DE FRANCE
Organization address
address: Avenue d'Italie 33 contact info |
FR (PARIS) | participant | 0.00 |
16 |
FONDAZIONE TELETHON
Organization address
address: VIA VARESE 16/B contact info |
IT (ROMA) | participant | 0.00 |
17 |
FRAUNHOFER-GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V
Organization address
address: Hansastrasse 27C contact info |
DE (MUENCHEN) | participant | 0.00 |
18 |
FUNDACION PARA EL DESAROLLO DE LA INVESTIGACION EN GENOMICA Y PROTEOMICA
Organization address
address: Orense 69 Eurobuilding II 2do Piso contact info |
ES (MADRID) | participant | 0.00 |
19 |
GENIKI GRAMMATIA EREVNAS KAI TECHNOLOGIAS
Organization address
address: Mesogeion Avenue 14-18 contact info |
EL (ATHENS) | participant | 0.00 |
20 |
HARIDUS-JA TEADUS MINISTEERIUM
Organization address
address: "Munga, 18" contact info |
EE (TARTU) | participant | 0.00 |
21 |
HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH
Organization address
address: Ingolstaedter Landstrasse 1 contact info |
DE (MUENCHEN) | participant | 0.00 |
22 |
HERMANN VON HELMHOLTZ-GEMEINSCHAFT DEUTSCHER FORSCHUNGSZENTRUM EV
Organization address
address: Ahrstrasse 45 contact info |
DE (BONN) | participant | 0.00 |
23 |
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
Organization address
address: 101 Rue de Tolbiac contact info |
FR (PARIS) | participant | 0.00 |
24 |
INSTITUT NATIONAL DU CANCER
Organization address
city: Boulogne-Billancourt contact info |
FR (Boulogne-Billancourt) | participant | 0.00 |
25 |
INSTITUTO DE SALUD CARLOS III
Organization address
address: CALLE SINESIO DELGADO 4-6 contact info |
ES (MADRID) | participant | 0.00 |
26 |
INTERNATIONAL PREVENTION RESEARCH INSTITUT-IPRI MANAGEMENT
Organization address
address: COURS LAFAYETTE 95 contact info |
FR (LYON) | participant | 0.00 |
27 |
IRCCS AZIENDA OSPEDALIERA UNIVERSITARIA SAN MARTINO-IST-ISTITUTO NAZIONALE PER LA RICERCA SUL CANCRO
Organization address
address: LARGO ROSANNA BENZI 10 contact info |
IT (GENOVA) | participant | 0.00 |
28 |
IRISH PLATFORM FOR PATIENTS' ORGANISATIONS SCIENCE AND INDUSTRY LIMITED BY GUARANTEE
Organization address
address: GROVE ROAD 1 LA TOUCHE HOUSE 1 contact info |
IE (DUBLIN) | participant | 0.00 |
29 |
ISLENSK ERFDAGREINING EHF
Organization address
address: Sturlugata 8 contact info |
IS (REYKJAVIK) | participant | 0.00 |
30 |
ISTITUTO NAZIONALE PER LA RICERCA SUL CANCRO
Organization address
address: Largo Rosanna Benzi 10 contact info |
IT (GENOVA) | participant | 0.00 |
31 |
KAROLINSKA INSTITUTET
Organization address
address: Nobels Vag 5 contact info |
SE (STOCKHOLM) | participant | 0.00 |
32 |
LEGAL PATHWAYS BV
Organization address
address: KLAPHEKLAAN 8 contact info |
NL (AERDENHOUT) | participant | 0.00 |
33 |
LIFE SCIENCE GOVERNANCE INSTITUTE
Organization address
address: Schottenfeldgasse 29 contact info |
AT (vienna) | participant | 0.00 |
34 |
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN E.V.
Organization address
address: Hofgartenstrasse 8 contact info |
DE (MUENCHEN) | participant | 0.00 |
35 |
MEDICAL RESEARCH COUNCIL
Organization address
address: NORTH STAR AVENUE POLARIS HOUSE contact info |
UK (SWINDON) | participant | 0.00 |
36 |
MERIEUX ALLIANCE SA
Organization address
address: RUE BOURGELAT 17 contact info |
FR (LYON) | participant | 0.00 |
37 |
MOLECULAR MEDICINE IRELAND LBG
Organization address
address: ST STEPHENS GREEN 85A contact info |
IE (DUBLIN) | participant | 0.00 |
38 |
NASJONALT FOLKEHELSEINSTITUTT
Organization address
address: Lovisenberggata 8 contact info |
NO (OSLO) | participant | 0.00 |
39 |
NEDERLANDSE FEDERATIE VAN UNIVERSITAIR MEDISCH CENTRA
Organization address
address: Oudlaan 4 contact info |
NL (UTRECHT) | participant | 0.00 |
40 |
NORGES TEKNISK-NATURVITENSKAPELIGEUNIVERSITET NTNU
Organization address
address: HOGSKOLERINGEN 1 contact info |
NO (TRONDHEIM) | participant | 0.00 |
41 |
PRESIDENZA DEL CONSIGLIO DEI MINISTRI.
Organization address
address: Piazza Colonna 370 - Palazzo Chigi contact info |
IT (ROMA) | participant | 0.00 |
42 |
SEMMELWEIS EGYETEM
Organization address
address: Ulloi ut 26 contact info |
HU (BUDAPEST) | participant | 0.00 |
43 |
TARTU ULIKOOL
Organization address
address: ULIKOOLI 18 contact info |
EE (TARTU) | participant | 0.00 |
44 |
TERVEYDEN JA HYVINVOINNIN LAITOS
Organization address
address: MANNERHEIMINTIE 166 contact info |
FI (HELSINKI) | participant | 0.00 |
45 |
THE HEALTH RESEARCH BOARD
Organization address
address: LOWER BAGGOT STREET 73 contact info |
IE (DUBLIN) | participant | 0.00 |
46 |
THE ICELANDIC CENTRE FOR RESEARCH
Organization address
address: Laugavegur 13 contact info |
IS (REYKJAVIK) | participant | 0.00 |
47 |
THE NETHERLANDS ORGANISATION FOR HEALTH RESEARCH AND DEVELOPMENT
Organization address
address: Laan Van Nieuw Oost Indie 334 contact info |
NL (DEN HAAG) | participant | 0.00 |
48 |
THE UNIVERSITY OF MANCHESTER
Organization address
address: OXFORD ROAD contact info |
UK (MANCHESTER) | participant | 0.00 |
49 |
TURUN YLIOPISTO
Organization address
address: YLIOPISTONMAKI contact info |
FI (TURUN YLIOPISTO) | participant | 0.00 |
50 |
UK BIOBANK LIMITED
Organization address
address: SPECTRUM WAY UNIT 1&2 ADSWOOD contact info |
UK (STOCKPORT) | participant | 0.00 |
51 |
UNIVERSIDAD DE SALAMANCA
Organization address
address: "Patio de Escuelas, 1" contact info |
ES (SALAMANCA) | participant | 0.00 |
52 |
UNIVERSITA TA MALTA
Organization address
address: University Campus, Tal-Qroqq contact info |
MT (MSIDA) | participant | 0.00 |
53 |
UNIVERSITAET KLAGENFURT
Organization address
address: UNIVERSITAETSSTRASSE 65-67 contact info |
AT (KLAGENFURT) | participant | 0.00 |
54 |
UPPSALA UNIVERSITET
Organization address
address: SANKT OLOFSGATAN 10 B contact info |
SE (UPPSALA) | participant | 0.00 |
55 |
VITRO S.A.
Organization address
address: CALLE LUIS FUENTES BEJARANO EDIFICIO NUDO NORTE LOCAL 3 60 contact info |
ES (SEVILLA) | participant | 0.00 |
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
'The Preparatory Phase for a pan-European Biobanking and Biomolecular Resources Research Infrastructure (BBMRI) will focus on technical, legal, governance, and financial issues to • prepare to construct BBMRI, building on existing biobanks, resources and technologies, specifically complemented with innovative components and properly embedded into European scientific, ethical, legal and societal frameworks, • provide the concept for a key resource to increase excellence and efficacy in biomedical sciences, drug development and public health, • expand and secure competitiveness of European research and industry in a global context, • develop a sustainable financial framework. Biomedical quality-assessed samples and data as well as biomolecular resources and molecular analysis tools are essential for academic and industry-driven research to treat and prevent human diseases. Although currently established national biobanks and biomolecular resources are a unique European strength, valuable collections typically suffer from fragmentation of the European biobanking-related research community. This hampers the collation of biological samples and data from different biobanks required to achieve sufficient statistical power. Moreover, it results in duplication of effort and jeopardises sustainability due to the lack of long-term funding. BBMRI will comprise: • biobanks of different formats (collections of blood, DNA, tissue, etc., together with medical, environmental, life-style and follow-up data), • biomolecular resources (antibody and affinity binder collections, ORF clone collections, siRNA libraries, proteins, cellular resources etc.), • enabling technologies and high-throughput analysis platforms and molecular tools to decipher gene, protein and metabolite functions and their interactions, • harmonized standards for sample collection, storage, preanalytics and analysis • harmonized databases and biocomputing infrastructure, • ethical, legal and societal'
Biomedical research is highly dependent on the availability of human samples. A pan-European effort for an integrated biobank infrastructure will facilitate research and development.
Biological samples of healthy subjects or patients alongside clinical data constitute the foundation of most biomedical studies. Such samples are central to unravelling the complexity of the human body and identifying novel therapeutic targets for challenging diseases such as cancer.
The scope of the EU-funded http://bbmri-eric.eu/ (BBMRI) (Biobanking and biomolecular resources research infrastructure) effort was to integrate existing biobanks and resources across Europe into a pan-European infrastructure. The consortium comprised 54 participants and 224 associated organisations from 33 countries.
The BBMRI consortium has integrated existing quality controlled biobanks, biomolecular resources and enabling technologies into a novel pan-European Biomedical Research Infrastructure-European Research Infrastructure Consortium (BBMRI-ERIC). ERIC is a legal entity with legal personality and full legal capacity recognised in all EU Member States.
BBMRI-ERIC is centrally coordinated by Austria and provides national hubs, established in participating countries, to grant electronic access to resources, support and expertise. Each hub was responsible for granting the national scientific community access to these resources.
The project successfully provided comprehensive information, standard operational procedures and codes of conduct for European biobanks. A step by step access policy on human biological samples and associated data was implemented as well as an inventory of existing major population-based and clinical (disease-orientated) biobanks in Europe. Furthermore, the activities of BBMRI ensured that technologies and reagents were available to make optimal use of patient sample collections. A new http://www.molmeth.org (database) for molecular methods was also introduced.
One of the major challenges was the generation of an IT-infrastructure capable of linking the existing biobank data with patient registries and clinical information. In this context, partners established a publicly accessible, common web-based portal as a centralised information site for European technology resources and platforms serving the major biobanks. The portal is functional and available at the http://www.bbmri-wp4.eu/resources (BBMRI website).
BBMRI is anticipated to operate as a bridge between sample donors and scientists performing biomedical research. Equally importantly, it will act as a firewall preventing certain types of personal information from flowing inappropriately between donors and researchers.
With adequate support and technical advancement, a pan-European biobanking infrastructure should also facilitate the new concept of personalised medicine. In this context, biobank-derived material could be used to develop new diagnostic tools and therapeutic agents to identify disease subgroups and specifically target them.
The activities of the BBMRI consortium received considerable attention with broad coverage in the press. Overall, a central European biobank infrastructure will undoubtedly support current research efforts and hopefully lead to improved health products and services.